Apogee Therapeutics Newsroom

Guggenheim Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $110

Futu NewsNov 27 20:33

CCORF Initiates Apogee Therapeutics(APGE.US) With Buy Rating, Announces Target Price $89

Futu NewsNov 25 19:33

Apogee Therapeutics Price Target Announced at $89.00/Share by Canaccord Genuity

Dow JonesNov 25 19:32

Apogee Therapeutics Initiated at Buy by Canaccord Genuity

Dow JonesNov 25 19:32

Apogee Therapeutics Analyst Ratings

BenzingaNov 25 19:23

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $100

Futu NewsNov 13 19:31

TD Cowen Maintains Apogee Therapeutics(APGE.US) With Buy Rating

Futu NewsNov 13 03:31

Promising Advancements and Strategic Positioning Propel Apogee Therapeutics, Inc. to a Buy Rating

TipRanksNov 13 02:37

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $100

Futu NewsOct 29 18:31

TD Cowen Maintains Apogee Therapeutics(APGE.US) With Buy Rating

Futu NewsOct 28 20:35

Apogee Therapeutics Price Target Maintained With a $87.00/Share by Wedbush

Dow JonesOct 25 23:19

Apogee Therapeutics Analyst Ratings

BenzingaOct 25 23:10

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $81

Futu NewsSep 30 18:31

Buy Rating on Apogee Therapeutics' APG808: Market Potential and Treatment Advantages Amid FDA Approval Landscape

TipRanksSep 30 17:40

BofA Securities Initiates Apogee Therapeutics(APGE.US) With Buy Rating, Announces Target Price $80

Futu NewsAug 13 17:33

Apogee Therapeutics, Inc. (APGE) Receives a Buy From TD Cowen

TipRanksAug 13 00:51

Buy Rating for Apogee Therapeutics: Promising Prospects for Dupixent and APG808 in COPD Market

TipRanksJun 1 05:17

Buy Rating on Apogee Therapeutics: Promising Drug Developments and Strong Financials

TipRanksMay 14 07:00

Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)

TipRanksMay 13 23:25

Apogee Therapeutics Analyst Ratings

BenzingaMay 10 18:55